Literature DB >> 14630800

Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.

Marieke Levitus1, Martin A Rooimans, Jûrgen Steltenpool, Nicolle F C Cool, Anneke B Oostra, Christopher G Mathew, Maureen E Hoatlin, Quinten Waisfisz, Fré Arwert, Johan P de Winter, Hans Joenje.   

Abstract

Fanconi anemia (FA) is an autosomal recessive syndrome featuring diverse symptoms including progressive bone marrow failure and early occurrence of acute myeloid leukemia. Nine genetic subtypes have been described for FA (A, B, C, D1, D2, E, F, G, and L), all of which have been connected to distinct disease genes, except B. Here we report on 8 unrelated FA patients who were excluded from the known subtypes on the basis of phenotypic correction or genetic data. Four of these cell lines failed to complement each other in somatic cell hybrids and therefore represent a new group, termed FA-I. The remaining cell lines complemented group FA-I but did not complement each other, thus representing a second new group, FA-J. Both FA-I and -J cell lines were capable of forming an FA multiprotein core complex. This complex is required for activation of the FANCD2 protein by mono-ubiquitination, a key downstream event in the FA pathway. In FA-I cells FANCD2 was not mono-ubiquitinated, indicating a defect upstream in the FA pathway, whereas in FA-J cells FANCD2 was mono-ubiquitinated, indicating a downstream defect. Our results suggest that the FA pathway of genome stabilization may be controlled by at least 11 different genes, including FANCI and FANCJ.

Entities:  

Mesh:

Year:  2003        PMID: 14630800     DOI: 10.1182/blood-2003-08-2915

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  Molecular cross-talk among chromosome fragility syndromes.

Authors:  Jordi Surrallés; Stephen P Jackson; Maria Jasin; Michael B Kastan; Stephen C West; Hans Joenje
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

2.  A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M.

Authors:  Amom Ruhikanta Meetei; Annette L Medhurst; Chen Ling; Yutong Xue; Thiyam Ramsing Singh; Patrick Bier; Jurgen Steltenpool; Stacie Stone; Inderjeet Dokal; Christopher G Mathew; Maureen Hoatlin; Hans Joenje; Johan P de Winter; Weidong Wang
Journal:  Nat Genet       Date:  2005-08-21       Impact factor: 38.330

3.  Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca-/- and Fancg-/- mice.

Authors:  Yue Si; Samantha Ciccone; Feng-Chun Yang; Jin Yuan; Daisy Zeng; Shi Chen; Henri J van de Vrugt; John Critser; Fre Arwert; Laura S Haneline; D Wade Clapp
Journal:  Blood       Date:  2006-08-31       Impact factor: 22.113

Review 4.  Molecular pathogenesis of Fanconi anemia.

Authors:  Natalie Collins; Gary M Kupfer
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

5.  Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM.

Authors:  Seiki Hirano; Kazuhiko Yamamoto; Masamichi Ishiai; Mitsuyoshi Yamazoe; Masayuki Seki; Nobuko Matsushita; Mioko Ohzeki; Yukiko M Yamashita; Hiroshi Arakawa; Jean-Marie Buerstedde; Takemi Enomoto; Shunichi Takeda; Larry H Thompson; Minoru Takata
Journal:  EMBO J       Date:  2004-12-23       Impact factor: 11.598

6.  Evidence for subcomplexes in the Fanconi anemia pathway.

Authors:  Annette L Medhurst; El Houari Laghmani; Jurgen Steltenpool; Miriam Ferrer; Chantal Fontaine; Jan de Groot; Martin A Rooimans; Rik J Scheper; Amom Ruhikanta Meetei; Weidong Wang; Hans Joenje; Johan P de Winter
Journal:  Blood       Date:  2006-05-23       Impact factor: 22.113

7.  FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway.

Authors:  Chen Ling; Masamichi Ishiai; Abdullah Mahmood Ali; Annette L Medhurst; Kornelia Neveling; Reinhard Kalb; Zhijiang Yan; Yutong Xue; Anneke B Oostra; Arleen D Auerbach; Maureen E Hoatlin; Detlev Schindler; Hans Joenje; Johan P de Winter; Minoru Takata; Amom Ruhikanta Meetei; Weidong Wang
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

8.  Natural gene therapy in monozygotic twins with Fanconi anemia.

Authors:  Anuj Mankad; Toshiyasu Taniguchi; Barbara Cox; Yassmine Akkari; R Keaney Rathbun; Lora Lucas; Grover Bagby; Susan Olson; Alan D'Andrea; Markus Grompe
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

9.  Defects of FA/BRCA pathway in lymphoma cell lines.

Authors:  Hui Xiao; Ke Jian Zhang; Bing Xia
Journal:  Int J Hematol       Date:  2008-11-15       Impact factor: 2.490

Review 10.  TNF-α, a good or bad factor in hematological diseases?

Authors:  Tian Tian; Min Wang; Daoxin Ma
Journal:  Stem Cell Investig       Date:  2014-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.